CHM — Chimeric Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$24.68m
- AU$23.79m
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Changes in Working Capital | — | — | -0.003 | 3.53 |
Other Operating Cash Flow | ||||
Cash from Operating Activities | -0.034 | -8.84 | -13.2 | -16.3 |
Capital Expenditures | — | -5.31 | -0.538 | -0.112 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | 0 | 0.003 | -0.04 | 0 |
Other Investing Cash Flow | ||||
Cash from Investing Activities | 0 | -5.3 | -0.578 | -0.112 |
Financing Cash Flow Items | — | -2.72 | -1.31 | -0.099 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0.034 | 36.5 | 9.54 | 0.253 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0 | 22.4 | -4.03 | -16 |